Ceapro Extends Agreement with SymriseWe can only hope that more will come out of this Agreement than the last one.
After the closing of the last agreement (published on 10.3.22 closing as of 1.1.22) we have seen in III./IV. Quarter 2022 as well as I Quarter 2023 we have seen declining sales.
We will see shortly if sales have stabilized or if the weak trend continues.
This publication is also not conducive to finding new buyers for our shares!